Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
CARDIOLOGY SOCIETY DEVELOPMENT from Vorst, company number BE0899334708, closed financial year 2025 with a result of € 138,956 after tax. For that financial year CARDIOLOGY SOCIETY DEVELOPMENT recorded revenue of € 725,873 and equity of € -68,954. Compared with financial year 2022, the result moved from € 74,673 to € 138,956. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 10, 2025.
€ -68,954
▲ € 274,839 vs 2022
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 138,956
▲ 86% vs 2022
Profit after tax over the fiscal year.
€ 101,600
▲ 113% vs 2022
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -75,154.
People and assets in 2025
€ 7,969
▼ 45% vs 2022
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 24,434
▼ 9% vs 2022
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 310,275
▲ 1% vs 2022
€ 92,223 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 23,097
▲ 158% vs 2022
Supplier invoices still open on the last day of the fiscal year.
€ 11,200
▼ 4% vs 2022
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2020 | 2021 | 2022 | 2025 | Change 2022 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 281,170 | € 340,226 | € 335,268 | € 725,873 | ▲ 117% |
| Gross margin | € 101,736 | € 5,780 | € 122,050 | € 199,192 | ▲ 63% |
| Profit after taxes | € 62,150 | € -42,292 | € 74,673 | € 138,956 | ▲ 86% |
| Equity | € -337,896 | € -380,188 | € -343,793 | € -68,954 | ▲ € 274,839 |
| Total debts | € 458,664 | € 554,036 | € 491,717 | € 344,572 | ▼ 30% |
| Cash | € 34,844 | € 92,244 | € 47,679 | € 101,600 | ▲ 113% |
| Land & buildings | € 5,371 | - | € 0 | € 3,377 | ▲ € 3,377 |
| Retained profit | € -344,096 | € -386,388 | € -349,993 | € -75,154 | ▲ € 274,839 |
| Bank debt | € 183,593 | € 182,167 | € 306,126 | € 310,275 | ▲ 1% |
| Balance sheet total | € 120,767 | € 173,848 | € 147,924 | € 275,618 | ▲ 86% |
Key figures of CARDIOLOGY SOCIETY DEVELOPMENT, fiscal years 2020 to 2025, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2026 has not been filed yet; it was expected before 31 August 2026.
What happened to CARDIOLOGY SOCIETY DEVELOPMENT?
What happened at CARDIOLOGY SOCIETY DEVELOPMENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 138,956 (▲ 86% vs 2022). filed late Source: NBB ↗
- New establishment in Vorst. KBO
- Start of the company according to the CBE. KBO
In short
From € 62,150 profit in 2020 to € 138,956 profit in 2025.
Paid € 44,870 in corporate taxes since 2020.
Best year ever: 2025, with € 138,956 profit.
A new publication or filing at CARDIOLOGY SOCIETY DEVELOPMENT? We notify you, reason included.
Follow CARDIOLOGY SOCIETY DEVELOPMENTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Zijdeweverijstraat 21
1190 Vorst
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0899.334.708
- VAT number
- BE 0899.334.708
- Registered office
- Zijdeweverijstraat 21, 1190 Vorst
- Names & denominations
- CARDIOLOGY SOCIETY DEVELOPMENT · CSD
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 July 2008
- Peppol
- Not registered
- Activities · NACE
Activiteiten van medisch specialisten